Skip to main content
OpenTrials

Clinical trial condition

Endometrial Carcinoma

Explore clinical trials studying Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.

79 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Carcinoma trial results

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions
Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations
  • Arizona Cancer Center Tuscon, Arizona, United States
  • Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
  • H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
  • Nevada Cancer Institute Sparks, Nevada, United States
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT01366144

Conditions
Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details

Related conditions